Xuejiao Bai

Title: Xuejiao Bai: Innovator in Polypeptide Magnetic Nanoparticles

Introduction

Xuejiao Bai is an accomplished inventor based in Beijing, China. She is currently associated with Beijing Nanopep Biotech Corporation, Ltd. Despite having no granted patents to her name, her work in the field of biotechnology is noteworthy. Bai's research focuses on the development of innovative solutions for cancer detection and treatment.

Latest Patent Applications

Xuejiao Bai's latest patent application is titled "Polypeptide Magnetic Nanoparticle, Preparation Method Therefor and Use Thereof." This application describes a polypeptide magnetic nanoparticle that includes a specific targeting polypeptide and a magnetic nanoparticle. The amino acid sequence of the specific targeting polypeptide is VRRDAPRFSMQGLDA-X, where the C-terminal X consists of a sequence of 5 to 20 amino acids. The amino acids in this sequence can be selected from one or more of C, G, and N. This innovative nanoparticle is designed for circulating tumor cell (CTC) detection and molecular typing of various cancer types, including esophageal, liver, lung, stomach, bladder, skin, melanoma, breast, colorectal, and cervical cancers. The biomarkers for CTC molecular typing include PD-L1, HER2, ER, PR, AR, EGFR, VEGFR, and CXCR4. The polypeptide magnetic nanoparticle aids in CTC detection and allows for qualitative and semiquantitative analysis of biomarker expression levels at the CTC level. This technology is pivotal for implementing precise therapies, such as targeted individualized therapy or immunotherapy for patients.

Conclusion

Xuejiao Bai is making significant strides in the field of biotechnology, particularly in cancer detection and treatment through her innovative research on polypeptide magnetic nanoparticles. Her contributions hold promise for advancing medical technology and improving patient outcomes.